Аn overview of cardiovascular risks in patients with type 2 diabetes receiving glibenclamide

Abstract

Diabetes mellitus type 2 is a chronic progressive disease which leads to specific vascular complications - microangiopathy and macroangiopathy. These complications are the reason of increased cardiovascular mortality, which is 4-5 times higher in patients with type 2 diabetes mellitus than in the general population.

Keywords

• diabetes mellitus
• vascular complications
• antihyperglycemic drugs
• glibenclamide
• сахарный диабет
• сосудистые осложнения
• сахароснижающие препараты
• глибенкламид